In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma

The long-term overall survival of Ewing sarcoma (EWS) patients remains poor; less than 30% of patients with metastatic or recurrent disease survive despite aggressive combinations of chemotherapy, radiation and surgery. To identify new therapeutic options, we employed a multi-pronged approach using...

Descripción completa

Detalles Bibliográficos
Autores principales: Pessetto, Ziyan Y., Chen, Bin, Alturkmani, Hani, Hyter, Stephen, Flynn, Colleen A., Baltezor, Michael, Ma, Yan, Rosenthal, Howard G., Neville, Kathleen A., Weir, Scott J., Butte, Atul J., Godwin, Andrew K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354814/
https://www.ncbi.nlm.nih.gov/pubmed/27863422
http://dx.doi.org/10.18632/oncotarget.13385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354814/
https://www.ncbi.nlm.nih.gov/pubmed/27863422
http://dx.doi.org/10.18632/oncotarget.13385

Ejemplares similares